Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00733291 |
|
Recruitment Status :
Completed
First Posted : August 13, 2008
Results First Posted : December 21, 2011
Last Update Posted : December 28, 2011
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Myopia | Device: Nelfilcon A contact lens Device: Etafilcon A contact lens Device: FID 107027 solution | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 64 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Double (Participant, Investigator) |
| Study Start Date : | January 2008 |
| Actual Primary Completion Date : | February 2008 |
| Actual Study Completion Date : | February 2008 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Nelfilcon A soak / Nelfilcon A no-soak
Nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by nelfilcon A contact lenses inserted directly from the blister package. Each pair of lenses worn for 2 hours.
|
Device: Nelfilcon A contact lens
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Name: Focus Dailies with AquaRelease Device: FID 107027 solution Commercially marketed solution for contact lens disinfection
Other Name: Opti-Free RepleniSH Multi-Purpose Disinfecting Solution |
|
Active Comparator: Nelfilcon A no soak / nelfilcon A soak
Nelfilcon A contact lenses inserted directly from the blister package, followed by nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution. Each pair of lenses worn for 2 hours.
|
Device: Nelfilcon A contact lens
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Name: Focus Dailies with AquaRelease Device: FID 107027 solution Commercially marketed solution for contact lens disinfection
Other Name: Opti-Free RepleniSH Multi-Purpose Disinfecting Solution |
|
Active Comparator: Etafilcon A soak / etafilcon A no soak
Etafilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by etafilcon A contact lenses inserted directly from the blister package. Each pair of lenses worn for 2 hours.
|
Device: Etafilcon A contact lens
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Name: 1-Day ACUVUE Moist Device: FID 107027 solution Commercially marketed solution for contact lens disinfection
Other Name: Opti-Free RepleniSH Multi-Purpose Disinfecting Solution |
|
Active Comparator: Etafilcon A no soak / etafilcon A soak
Etafilcon A contact lenses inserted directly from the blister package, followed by etafilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution. Each pair of lenses worn for 2 hours.
|
Device: Etafilcon A contact lens
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Name: 1-Day ACUVUE Moist Device: FID 107027 solution Commercially marketed solution for contact lens disinfection
Other Name: Opti-Free RepleniSH Multi-Purpose Disinfecting Solution |
- Average Corneal Staining Area [ Time Frame: After 2 hours of wear ]Percentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.
- Total Corneal Staining Type [ Time Frame: After 2 hours of wear ]Total corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (>/= 1mm). The five regions were summed.
- Ocular Comfort [ Time Frame: After 2 hours of wear ]Ocular comfort was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, "Right now my eyes feel..." with one of the following responses: 1-very comfortable; 2-comfortable; 3-neither comfortable nor uncomfortable; 4-uncomfortable; 5-very uncomfortable.
- Ocular Redness [ Time Frame: After two hours of wear ]Ocular redness was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, "Right now my eyes look..." with one of the following responses: 1-very white; 2-white; 3-neither white nor red; 4-red; 5-very red.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years of age or older.
- Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses.
- Successfully wearing hydrogel or silicone hydrogel contact lenses on a daily wear basis for at least two weeks prior to study.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- History of hypersensitivity to any components of the multi-purpose solution.
- Evidence or history of ocular conditions as prescribed in protocol.
- One functional eye or a monofit lens
- Any slit-lamp finding score equal to 1 at Visit 1 of each study period.
- Significant corneal staining at visit 1 of each study period as prescribed in protocol.
- Other protocol-defined exclusion criteria may apply.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00733291
| United States, Texas | |
| Contact Alcon Call Center for Trial Locations | |
| Fort Worth, Texas, United States, 76134 | |
| Responsible Party: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT00733291 |
| Other Study ID Numbers: |
MS-008 |
| First Posted: | August 13, 2008 Key Record Dates |
| Results First Posted: | December 21, 2011 |
| Last Update Posted: | December 28, 2011 |
| Last Verified: | December 2011 |
|
Daily disposable contact lenses Multi-purpose disinfecting solutions |
|
Myopia Refractive Errors Eye Diseases Pharmaceutical Solutions |

